Trade Mark Journal No.2026/003 16 January 2026
WO0000001892852 (42)
Office of origin: United States of America
Date of International Registration:21 July 2025
Date of designation in the UK:
21 July 2025
The mark consists of of the stacked words "CLINICAL CONTROL", "CENTER" and "BY BCG X"; all to the left and partially overlapping a slash design.
Registration of this mark shall give no rights to the exclusive use of 'CLINICAL CONTROL CENTER'.
International priority date claimed: 21 January 2025
(United States of America)
(99013764)
- Class 42
- Providing temporary use of online non-downloadable software for business process management; providing temporary use of online non-downloadable software using generative artificial intelligence (AI) to assist businesses with clinical trial design, execution, evaluation, and drafting or related reports; providing temporary use of online non-downloadable software to automate document writing for the design, execution, and evaluation of clinical trials; providing temporary use of online non-downloadable software for business management and optimization purposes using technical data, data modelling, AI modelling, and algorithmic processes; providing technological consulting services to businesses in the field of clinical trial optimization, maximizing cost efficiency, and improving success rates; providing scientific and technological consulting services for others with regard to the design, planning, management, and optimization of scientific research and clinical trials.
The Boston Consulting Group, Inc.
Representative: Michael Geller DLA Piper LLP (US), 444 West Lake Street, Suite 900, Chicago IL 60606, UNITED STATES OF AMERICA